Approved for type 2 diabetes and showing significant weight-loss benefits, with pending approval for obesity treatment
GLP-1s are becoming a mainstay for weight loss and diabetes treatment, and the demand for this type of drug is high
These medications may also help lower blood pressure, improve lipid disorders and fatty liver disease, slow diabetes-related neuropathy, and reduce the risk of heart and kidney disease
In May 2022, tirzepatide (marketed as Mounjaro) received FDA approval for improving blood sugar control in adults with type 2 diabetes, in combination with diet and exercise
9 Furthermore, exenatide is FDA approved to be used as monotherapy along with appropriate diet and exercise modifications
Metabolic Stability: By prompting the pancreas to release insulin only when necessary, they prevent dangerous blood sugar spikes and energy crashes, providing a steadier fuel source for your daily life